Forte Biosciences extends rights agreement expiration to July 2024; sets 2023 annual meeting for September 19

Forte Biosciences, Inc.

Amendment No. 1 extends Rights Agreement expiration to 5:00 p.m. ET on July 12, 2024, unless earlier redeemed or exchanged.
2023 Annual Meeting of Stockholders scheduled for September 19, 2023.
Stockholder proposals for proxy inclusion or director nominations must be received by July 6, 2023.
All other terms of the Rights Agreement remain unchanged.

item 1.01 item 3.03 item 5.08 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Forte Biosciences, Inc. amended Preferred Stock Rights Agreement, as amended by Amendment No. 1 to the Rights Agreement with Computershare Trust Company, N.A. valued at Extends expiration of Rights to 5:00 p.m., New York City time, on July 12, 2024 (effective 2023-06-26).

Action: amendment
Counterparty: Computershare Trust Company, N.A.
Value: Extends expiration of Rights to 5:00 p.m., New York City time, on July 12, 2024
Effective: 2023-06-26

Exact text from the filing

On June 26, 2023, the Company entered into Amendment No. 1 to the Rights Agreement between the Company and Computershare Trust Company, N.A., as rights agent (the “Amendment”), which amends the Rights Agreement.

View on SEC.gov

Browse all material agreements →

Forte Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-175223

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.